INVA (Innoviva) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INVA Innoviva Inc INVA
90 GF Score
Price $20.50
GF Value $23.00
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Innoviva Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

INVA
90GF Score
Innoviva Inc INVA
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Innoviva (INVA) Overvalued in 2026?

Based on GuruFocus' analysis, Innoviva stock appears to be undervalued. The current stock price of $20.50 is trading 10.9% below its estimated GF Value™ of $23.00. GuruFocus considers Innoviva to be Modestly Undervalued.

Key valuation signals for INVA:

  • Dividends Received:
  • GF Value™: $23.00 vs. price of $20.50 (10.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the INVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innoviva Business Description

Other Exchanges HVE:Germany
Address 1350 Old Bayshore Highway, Suite 400, Burlingame, CA, USA, 94010
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
90GF Score

Get the complete analysis for INVA

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.50
Price
$23.00
GF Value